RNA polymerase errors cause splicing defects and can be regulated by differential expression of RNA polymerase subunits
Abstract
Errors during transcription may play an important role in determining cellular phenotypes: the RNA polymerase error rate is >4 orders of magnitude higher than that of DNA polymerase and errors are amplified >1000-fold due to translation. However, current methods to measure RNA polymerase fidelity are low-throughout, technically challenging, and organism specific. Here I show that changes in RNA polymerase fidelity can be measured using standard RNA sequencing protocols. I find that RNA polymerase is error-prone, and these errors can result in splicing defects. Furthermore, I find that differential expression of RNA polymerase subunits causes changes in RNA polymerase fidelity, and that coding sequences may have evolved to minimize the effect of these errors. These results suggest that errors caused by RNA polymerase may be a major source of stochastic variability at the level of single cells.
https://doi.org/10.7554/eLife.09945.001eLife digest
Genes encode instructions to make proteins and other molecules. To issue an instruction, a gene is first used as a template to make molecules of ribonucleic acid (called mRNAs for short) in a process called transcription. An enzyme called RNA polymerase – which comprises several protein subunits that all work together – is responsible for making the mRNA molecules. Occasionally, this enzyme makes mistakes that lead to small changes in the instruction that is produced. These mistakes are rare, but because cells make thousands of mRNAs, a single human cell can make 10-100 transcription errors per second.
It has been difficult to study how often RNA polymerase makes mistakes and what effect these mistakes have on organisms because the techniques available for research are labour-intensive and technically challenging. Here, Lucas Carey demonstrates that it is possible to use a technique called RNA sequencing to study the accuracy of RNA polymerase in human and yeast cells.
The experiments show that altering the levels of the different subunits of RNA polymerase in cells can change how many mistakes are made during transcription. This suggests that cells may be able regulate number of mistakes by controlling the production of specific subunits. Carey found that the severity of the mistakes made by RNA polymerase depends on where the mistake is in the mRNA. For example, errors in specific parts of the mRNA can alter how the whole instruction is edited later, while others might make only a tiny change to the protein encoded by the gene. Carey also found evidence that the instructions encoded by genes may have evolved in such a way to minimise the effect of any errors on their roles in cells.
RNA sequencing is less labour-intensive than other methods used to study the accuracy of RNA polymerase and is already used to address other research questions on a wide variety of different organisms. Therefore, Carey’s findings will make it easier to study what genes or environmental factors influence the number of errors made during transcription. A major challenge for the future is to find out if the mistakes made by RNA polymerase can lead to cancer and other human diseases.
https://doi.org/10.7554/eLife.09945.002Main text
The information that determines protein sequence is stored in the genome, but that information must be transcribed by RNA polymerase and translated by the ribosome before reaching its final form. DNA polymerase error rates have been well characterized in a variety of species and environmental conditions, and are low – on the order of one mutation per 108–1010 bases per generation (Lynch, 2011; Lang and Murray, 2008; Zhu et al., 2014). In contrast, RNA polymerase errors are uniquely positioned to generate phenotypic diversity. Error rates are high (10-6–10-5) (Gout et al., 2013; Lynch, 2010; Shaw et al., 2002; de Mercoyrol et al., 1992), and each mRNA molecule is translated into 2000–4000 molecules of protein (Schwanhäusser et al., 2011; Futcher et al., 1999), resulting in the amplification of any errors. Likewise, because many RNAs are present at an average of less than one molecule per cell in microbes (Pelechano et al., 2010) and in embryonic stem cells (Islam et al., 2011), an RNA with an error may be the only RNA for that gene; all newly translated protein will contain this error. Despite the fact that transient errors can result in altered phenotypes (Gordon et al., 2013, 2015), the genetics and environmental factors that affect RNA polymerase fidelity are poorly understood. This is because current methods for measuring polymerase fidelity are technically challenging (Gout et al., 2013), require specialized organism-specific genetic constructs (Irvin et al., 2014), and can only measure error rates at specific loci (Imashimizu et al., 2013).
To overcome these obstacles I developed MORPhEUS (Measurement Of RNA Polymerase Errors Using Sequencing), which enables measurement of differential RNA polymerase fidelity using existing RNA-seq data (Figure 1). The input is a set of RNA-seq fastq files and a reference genome, and the output is the error rate at each position in the genome. I find that RNA polymerase errors result in intron retention and that cellular mRNA quality control may reduce the effective RNA polymerase error rate. Moreover, my analyses suggest that the expression level of the RPB9 Pol II subunits Rpb9 and Dst1 (TFIIS) determines RNA polymerase fidelity in vivo. Because it can be run on any existing RNA-seq data, MORPhEUS enables the exploration of a previously unexplored source of biological diversity in microbes and mammals.
Technical errors from reverse transcription and sequencing, and biological errors from RNA polymerase look identical (single-nucleotide differences from the reference genome). Therefore, a major challenge in identifying single-nucleotide polymorphisms (SNPs) and in measuring changes in polymerase fidelity is the reduction of technical errors (Kleinman and Majewski, 2012; Pickrell et al., 2012; Li et al., 2011) (Figure 1). First, I map full-length (untrimmed) reads to the genome and discard reads with indels, with more than two mismatches, that map to multiple locations in the genome, and that do not map end to end along the full length of the read. Next, I trim the ends of the mapped reads, as alignments are of lower quality along the ends, and the mismatch rate is higher, especially at splice junctions. I also discard any cycles within the run with abnormally high error rates, and bases with low Illumina quality scores (Figure 1—figure supplement 1). Finally, using the remaining bases, I count the number of matches and mismatches to the reference genome at each position in the genome. I discard positions with identical mismatches that are present more than once, as these are likely due to subclonal DNA polymorphisms or sequences that Illumina miscalls in a systematic manner (Meacham et al., 2011) (Figure 1—figure supplement 2). The result is a set of mismatches, many of which are technical errors and some of which are RNA polymerase errors. In order to determine if RNA-seq mismatches are due to RNA polymerase errors, it is necessary to identify sequence locations in which RNA polymerase errors are expected to have a measurable effect, or situations in which RNA polymerase fidelity is expected to vary.
I reasoned that RNA polymerase errors that alter positions necessary for splicing should result in intron retention, while sequencing errors should not affect the final structure of the mRNA (Figure 2a). However, mutations in the donor and acceptor splice sites also result in decreased expression (Jung et al., 2015), and therefore are difficult to measure using RNA-seq. Therefore, I used chromatin-associated and nuclear RNA from Hela and Huh7 cells (Dhir et al., 2015), and extracted all reads that span an exon–intron junction for introns with canonical GT and AG splice sites, and measured the RNA-seq mismatch rate at each position. I find that errors at the G and U in the 5’ donor site and at the A in the acceptor site are significantly enriched relative to errors at other positions (Figure 2b), and to errors in exonic trinucleotides at splicing motifs in the human genome (Figure 2—figure supplement 1) suggesting that RNA polymerase mismatches can result in changes in transcript isoforms. The ability of RNA polymerase errors to significantly affect splicing has been proposed (Fox-Walsh and Hertel, 2009) but never previously measured.
RPB9 is known to be involved in RNA polymerase fidelity in vitro and in vivo (Irvin et al., 2014; Knippa and Peterson, 2013). Therefore, I reasoned that cell lines expressing low levels of RPB9 would have higher RNA polymerase error rates. Consistent with this, I find that RPB9 expression varies eightfold across the ENCODE cell lines, and this expression variation is correlated with the RNA-seq error rate (Figure 2c, Figure 2—figure supplement 2). This suggests that low RPB9 expression may cause decreased polymerase fidelity in vivo.
In addition, export of mRNAs from the nucleus involves a quality-control mechanism that checks if mRNAs are fully spliced and have properly formed 5’ and 3’ ends (Lykke-Andersen, 2001). I hypothesized that mRNA export may involve a quality control that removes mRNAs with errors. I used the ENCODE dataset in which nuclear and cytoplasmic poly-A + mRNAs were sequenced; thus I can compare nuclear and cytoplasmic fractions from the same cell line grown in the same conditions and processed in the same manner. I find that the nuclear fraction has a higher RNA polymerase error rate than does the cytoplasmic fraction (Figure 2c,d), suggesting that either that nuclear RNA-seq has a higher technical error rate or that the cell has mechanisms for reducing the effective polymerase error rate by preventing the export of mRNAs that contain errors.
Rpb9 and Dst1 are known to be involved in RNA polymerase fidelity in vitro, yet there is conflicting evidence as to the role of Dst1 in vivo(Shaw et al., 2002; Irvin et al., 2014; Knippa and Peterson, 2013; Nesser et al., 2006; Walmacq et al., 2009; Kireeva et al., 2008). Part of these conflicts may result from the fact that the only available assays for RNA polymerase fidelity are special reporter strains that rely on DNA sequences known to increase the frequency of RNA polymerase errors. While I found that RPB9 expression correlates with RNA-seq error rates in mammalian cells, correlation is not causation. Furthermore, differences in RNA levels do not necessitate differences in stoichiometry among the subunits in active Pol II complexes. In order to determine if differential expression of RPB9 or DST1 are causative for differences in RNA polymerase fidelity in vivo, I constructed two yeast strains in which I can alter the expression of either RPB9 or DST1 using β-estradiol and a synthetic transcription factor that has no effect on growth rate or the expression of any other genes (Mcisaac et al., 2014, 2013). I grew these two strains (Z3EVpr-RPB9 and Z3EVpr-DST1) in different concentrations of β-estradiol and performed RNA-seq. I find that cells expressing low levels of RPB9 have high RNA polymerase error rates (Figure 3a). Likewise, cells with low DST1 have high error rates (Figure 3a). The increase in errors rate is not a property of cells defective for transcription elongation (Figure 3—figure supplement 1). The increase in error rates due to mutations in Rpb9 and Dst1 have not been robustly measured, however, there are some rough numbers. Here, the measured increase in error rate is 13%, while the measured effect of Rpb9 deletion in vitro is fivefold (Walmacq et al., 2009) and in vivo following reverse transcription is 30% (Nesser et al., 2006). If 2% of the observed mismatches are due to RNA polymerase errors, a fivefold increase in polymerase error rate results in a 10% increase in measured mismatch frequency; this is consistent with RNA polymerase fidelity of 10-6–10-5 and overall RNA-seq error rates of 10-4. Note that in our assay cells still express low levels or RPB9, and we therefore expect the increase in error rate to be lower, suggesting that RNA polymerase errors constitute 5–10% of the measured mismatches. Our ability to genetically control the expression of DST1 and RPB9, and measure changes in RNA-seq error rates is consistent with MORPhEUS measuring RNA polymerase fidelity. In addition, we observe more single-nucleotide insertions in the RNA-seq data from the high error rate samples, suggesting that depletion of RPB9 and DST1 results in increased insertions in transcripts, but not increased deletions (Figure 3—figure supplement 2). Finally, genetic reduction in RNA polymerase fidelity results in increased intron retention, consistent with RNA polymerase errors causing reduced splicing efficiency (Figure 3b).
A unique advantage of MORPhEUS is that it measures thousands of RNA polymerase errors across the entire transcriptome in a single experiment, and thus enables he complete characterization of the mutation spectrum and biases of RNA polymerase. I asked how altered RPB9 and DST1 expression levels affect each type of single-nucleotide change. I find that, with decreasing polymerase fidelity, transitions increase more than transversions, and that C→U errors are the most common (Figure 3c). This result, along with other sequencing based results (Gout et al., 2013), have shown that DNA and RNA polymerase have broadly similar error profiles (Zhu et al., 2014); it will be interesting to see if all polymerases share the same mutation spectra, and if this is due to deamination of the template base, or is a structural property of the polymerase itself. Interestingly, I find that coding sequences have evolved so that errors are less likely to produce in-frame stop codons than out-of-frame stop codons, suggesting that natural selection may act to minimize the effect of polymerase errors (Figure 4).
Here I have presented proof that relative changes in RNA polymerase error rates can be measured using standard Illumina RNA-seq data. Consistent with previous work in vivo and in vitro, I find that depletion of RPB9 or Dst1 results in higher RNA polymerase error rates. Furthermore, I find that expression of RPB9 negatively correlates with RNA-seq error rates in human cell lines, suggesting that differential expression of RPB9 may regulate RNA polymerase fidelity in vivo in humans. In addition, consistent with the errors detected by MORPhEUS being due to RNA polymerase and not technical errors, in reads spanning an exon–intron junction, the measured error rate is higher at the 5’ donor splice site, suggesting that RNA polymerase errors result in intron retention. Because it can be run on existing RNA-seq data, I expect MORPhEUS to enable many future discoveries regarding both the molecular determinants of RNA polymerase error rates and the relationship between RNA polymerase fidelity and phenotype.
Materials and methods
Counting RNA polymerase errors in already aligned ENCODE data
Request a detailed protocolMuch existing RNA-seq data is available as bam files aligned to the human genome. In order to bypass alignment, which is the most computationally expensive step of the pipeline, I developed a method capable of using RNA-seq reads aligned with spliced aligners. First, in order to avoid increased mismatch rates at splice junctions due to alignment problems with both spliced and unspliced reads, I used SAMtools (Li et al., 2009) and awk to remove all alignments that do not align along the full length of the genome (e.g., for 76 bp reads, only reads with a CIGAR flag of 76 M). The remaining reads weretrimmed (bamUtil, trimBam) to convert the first and last 10 bp of each read to Ns and set the quality strings to ‘!’. I then used samtools mpileup (-q30 –C50 –Q30) and custom perl code to count the number of reads and number of errors at each position in genome. Positions with too many errors (e.g., more than one read of the same nonreference base) were not counted.
Measurement of error rates at splice junctions
Request a detailed protocolI used the University of California Santa Cruz (UCSC) table browser (Karolchik, 2004) to download two bed files: hg19 EnsemblGenes introns with -10 bp flanking from each side, and another file with the introns and +10 bp flanking on either side. I then used bedtools (Quinlan and Hall, 2010) (bedtools flank -b 20 -l 0 and bedtools flank -l 20 -b 0) to generate bed files with intervals that contain the splicing donor and acceptor sites, respectively. In addition, I used bedtools getfasta on the +10 bp flanking bed file to keep only introns flanked by GT and AG donor and acceptor sites. The final result is a pair of bam files with intervals centered on the splicing donor or acceptor sites. I used this new bed file to count error rates around each splice junction. The error rate at each position (e.g., -10, -9, -8, etc. from the G at the 5’ donor site) is the sum of all errors at that position, divided by the sum of all reads. Positions are relative to the splicing feature, not to the genome, as error rates at any single genomic position are dominated by sampling bias. Per mono-, di-, and trinucleotide background error rates were-calculated using the same scripts, but without limiting mpileup to the splice junctions.
Strain construction and RNA sequencing for RPB9 and DST1 strains
Request a detailed protocolThe parental strain DBY12394 (Mcisaac et al., 2013) (GAL2 + s288c repaired HAP1, ura3∆, leu2∆0::ACT1pr-Z3EV-NatMX) was transformed with a polymerase chain reaction (PCR) product (KanMX-Z3EVpr) to generate a genomically integrated inducible RPB9 (LCY143) or DST1 (LCY142). To induce various levels of expression, strains were re-grown in YPD + 0-, 3-, 6-, 12-, or 25-nM β-estradiol (Sigma, St. Louis, MO, USA, E4389) for more than 12 hr to a final OD600 of 0.1 – 0.4. Cellular RNA was extracted using the Epicenter MasterPure RNA Purification Kit, and Illumina sequencing libraries were prepared using the Truseq Stranded mRNA kit, and sequenced on an HiSeq2000 with at least 20,000,000 50 bp sequencing reads per sample.
I used bwa (Li and Durbin, 2009) (-n 2, to permit no more than two mismatches in a read) to align the yeast RNA-seq reads to the reference genome, and trimBam from bamUtil to mask the first and last 10 bp of each read. I used samtools mpileup (Li et al., 2009) (-q 30 -d 100000 -C50 –Q39) to count the number of reads and mismatches at each position in the genome, discarding low confidence mapping, reads that map to multiple positions, and low quality reads. Duplicate reads can be removed from the fastq file if the coverage is low enough so that all reads that map to identical genome coordinates are expected be PCR duplicates from the same RNA fragment. This is the case for low coverage paired-end reads with a variable insert size, but not for very high coverage datasets or single-ended reads.
Pre-existing RNA-seq datasets
Request a detailed protocolFor the intron retention analysis in human cells, data are from NCBI SRA PRJNA253670. Data for the elc4 and spt4 analysis are from PRJNA167772 and PRJNA148851, respectively. For RPB9 correlation, undefined data (SRA PRJNA30709) are all from the Gingeras lab at CSHL.
Data availability
-
PRJNA289596Publicly available at the NCBI BioProject database (Accession no: PRJNA289596).
-
Home sapiens (human)Publicly available at the NCBI BioProject database (Accession no: PRJNA30709).
References
-
Microprocessor mediates transcriptional termination of long noncoding RNA transcripts hosting microRNAsNature Structural & Molecular Biology 22:319–327.https://doi.org/10.1038/nsmb.2982
-
Splice-site pairing is an intrinsically high fidelity processProceedings of the National Academy of Sciences of the United States of America 106:1766–1771.https://doi.org/10.1073/pnas.0813128106
-
Lost in transcription: transient errors in information transferCurrent Opinion in Microbiology 24:80–87.https://doi.org/10.1016/j.mib.2015.01.010
-
Large-scale detection of in vivo transcription errorsProceedings of the National Academy of Sciences of the United States of America 110:18584–18589.https://doi.org/10.1073/pnas.1309843110
-
Direct assessment of transcription fidelity by high-resolution RNA sequencingNucleic Acids Research 41:9090–9104.https://doi.org/10.1093/nar/gkt698
-
Intron retention is a widespread mechanism of tumor-suppressor inactivationNature Genetics 47:1242–1248.https://doi.org/10.1038/ng.3414
-
The UCSC table browser data retrieval toolNucleic Acids Research 32:493D–496.https://doi.org/10.1093/nar/gkh103
-
The sequence Alignment/Map format and SAMtoolsBioinformatics 25:2078–2079.https://doi.org/10.1093/bioinformatics/btp352
-
MRNA quality control: marking the message for life or deathCurrent Biology 11:R88–R91.https://doi.org/10.1016/S0960-9822(01)00036-7
-
Evolution of the mutation rateTrends in Genetics 26:345–352.https://doi.org/10.1016/j.tig.2010.05.003
-
The lower bound to the evolution of mutation ratesGenome Biology and Evolution 3:1107–1118.https://doi.org/10.1093/gbe/evr066
-
Rapid synthesis and screening of chemically activated transcription factors with GFP-based reportersJournal of Visualized Experiments e51153.https://doi.org/10.3791/51153
-
RNA polymerase II subunit Rpb9 is important for transcriptional fidelity in vivoProceedings of the National Academy of Sciences of the United States of America 103:3268–3273.https://doi.org/10.1073/pnas.0511330103
-
Use of an in vivo reporter assay to test for transcriptional and translational fidelity in yeastJournal of Biological Chemistry 277:24420–24426.https://doi.org/10.1074/jbc.M202059200
-
Rpb9 subunit controls transcription fidelity by delaying NTP sequestration in RNA polymerase IIJournal of Biological Chemistry 284:19601–19612.https://doi.org/10.1074/jbc.M109.006908
-
Rpb9 subunit controls transcription fidelity by delaying NTP sequestration in RNA polymerase IIJournal of Biological Chemistry 284:19601–19612.https://doi.org/10.1074/jbc.M109.006908
-
Precise estimates of mutation rate and spectrum in yeastProceedings of the National Academy of Sciences of the United States of America 111:E2310.https://doi.org/10.1073/pnas.1323011111
Article and author information
Author details
Funding
Agència de Gestió d’Ajuts Universitaris i de Recerca (2014 SGR 0974)
- Lucas B Carey
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
I thank members of the Carey lab and the computational genomics groups in the PRBB for thoughtful discussions.
Copyright
© 2015, Carey et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 10,491
- views
-
- 502
- downloads
-
- 42
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
- Microbiology and Infectious Disease
Timely and effective use of antimicrobial drugs can improve patient outcomes, as well as help safeguard against resistance development. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is currently routinely used in clinical diagnostics for rapid species identification. Mining additional data from said spectra in the form of antimicrobial resistance (AMR) profiles is, therefore, highly promising. Such AMR profiles could serve as a drop-in solution for drastically improving treatment efficiency, effectiveness, and costs. This study endeavors to develop the first machine learning models capable of predicting AMR profiles for the whole repertoire of species and drugs encountered in clinical microbiology. The resulting models can be interpreted as drug recommender systems for infectious diseases. We find that our dual-branch method delivers considerably higher performance compared to previous approaches. In addition, experiments show that the models can be efficiently fine-tuned to data from other clinical laboratories. MALDI-TOF-based AMR recommender systems can, hence, greatly extend the value of MALDI-TOF MS for clinical diagnostics. All code supporting this study is distributed on PyPI and is packaged at https://github.com/gdewael/maldi-nn.
-
- Computational and Systems Biology
- Genetics and Genomics
Enhancers and promoters are classically considered to be bound by a small set of transcription factors (TFs) in a sequence-specific manner. This assumption has come under increasing skepticism as the datasets of ChIP-seq assays of TFs have expanded. In particular, high-occupancy target (HOT) loci attract hundreds of TFs with often no detectable correlation between ChIP-seq peaks and DNA-binding motif presence. Here, we used a set of 1003 TF ChIP-seq datasets (HepG2, K562, H1) to analyze the patterns of ChIP-seq peak co-occurrence in combination with functional genomics datasets. We identified 43,891 HOT loci forming at the promoter (53%) and enhancer (47%) regions. HOT promoters regulate housekeeping genes, whereas HOT enhancers are involved in tissue-specific process regulation. HOT loci form the foundation of human super-enhancers and evolve under strong negative selection, with some of these loci being located in ultraconserved regions. Sequence-based classification analysis of HOT loci suggested that their formation is driven by the sequence features, and the density of mapped ChIP-seq peaks across TF-bound loci correlates with sequence features and the expression level of flanking genes. Based on the affinities to bind to promoters and enhancers we detected five distinct clusters of TFs that form the core of the HOT loci. We report an abundance of HOT loci in the human genome and a commitment of 51% of all TF ChIP-seq binding events to HOT locus formation thus challenging the classical model of enhancer activity and propose a model of HOT locus formation based on the existence of large transcriptional condensates.